| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 4 | 0.332 | 0.962 | 4.7E-03 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 2014 | 2019 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 1987 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2019 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
phenotype | 0.020 | None | 1.000 | 2 | 1 | 2016 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 0.982 | 335 | 1 | 2000 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 0.989 | 283 | 0 | 2000 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
phenotype | 0.100 | None | 0.947 | 281 | 1 | 1997 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
phenotype | 0.400 | None | 0.959 | 268 | 3 | 1990 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
phenotype | 0.400 | None | 0.971 | 245 | 4 | 1989 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 0.991 | 218 | 0 | 1984 | 2020 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
phenotype | 0.100 | None | 0.976 | 208 | 2 | 1994 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
phenotype | 0.100 | None | 0.989 | 174 | 1 | 1992 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
phenotype | 0.100 | None | 0.993 | 152 | 0 | 1995 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
phenotype | 0.100 | None | 0.992 | 129 | 1 | 1999 | 2020 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
phenotype | 0.100 | None | 0.989 | 94 | 2 | 1990 | 2019 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 82 | 1 | 1994 | 2019 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 0.984 | 63 | 0 | 2000 | 2020 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
phenotype | 0.100 | None | 0.978 | 46 | 0 | 2001 | 2019 | ||||||||
|
glutathione S-transferase pi 1 | 0.383 | 0.923 | 1.4E-02 |
|
phenotype | 0.100 | None | 0.977 | 43 | 1 | 1994 | 2020 | ||||||||
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
phenotype | 0.100 | None | 0.953 | 43 | 1 | 2007 | 2020 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
phenotype | 0.100 | None | 1.000 | 39 | 0 | 2002 | 2020 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 39 | 1 | 2005 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
phenotype | 0.100 | None | 1.000 | 38 | 0 | 2001 | 2019 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 37 | 0 | 1982 | 2019 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
phenotype | 0.100 | None | 1.000 | 37 | 0 | 2003 | 2019 |